Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07147192 · ClinicalTrials.gov registry record · NA

Feasibility Study of an Accommodating IOL Design

A NA study of Aphakia, sponsored by Alcon Research.

Recruiting
Registry status
NA
Development phase
85
Enrollment target
5
Study locations

NCT07147192 is a NA study of Aphakia that is actively recruiting participants, run by Alcon Research. The registered enrollment target is 85 participants, below the 198-participant average among 5 other Aphakia trials with a reported enrollment target (57% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07147192, a NA study of Aphakia, is actively recruiting participants, sponsored by Alcon Research.

RECRUITING
Registry status
NA
Development phase
85 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.

Conditions Studied

Aphakia

Interventions

  • PROCEDURE Phacoemulsification
  • DEVICE AAL-FAIOL
  • DEVICE BAL-FAIOL

Study Locations (5)

Other

  • Clinica 20/20 - San José
  • Instituto Espaillat Cabral - Santo Domingo
  • Centro Panamericano de Ojos / Clinica Lopez Beltran - San Salvador
  • Panama Eye Center - Panama City

Texas

  • Contact Alcon Call Center for Trial Locations - Fort Worth

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2025-12-03
Est. Completion 2027-11
Phase NA

Sponsor

Alcon Research

275 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07147192

The ClinicalTrials.gov registry entry for NCT07147192 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 198-participant average among 5 other Aphakia trials with a reported enrollment target (57% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aphakia appearing as the primary indexed condition, and to 3 interventions - of which Phacoemulsification is the first listed.

NCT07147192 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Other, Texas.

Frequently Asked Questions

What is clinical trial NCT07147192 about?

NCT07147192 is a clinical study titled "Feasibility Study of an Accommodating IOL Design". The purpose of this clinical study is to assess safety and explore usability and effectiveness of the test product, AAL-FAIOL. This study will be conducted in Central America.

What is the current status of trial NCT07147192?

This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2025-12-03. Estimated completion is 2027-11.

What conditions does trial NCT07147192 study?

This clinical trial studies the following conditions: Aphakia.

What interventions are being tested in trial NCT07147192?

The interventions under investigation include: Phacoemulsification (PROCEDURE), AAL-FAIOL (DEVICE), BAL-FAIOL (DEVICE).

Who is sponsoring clinical trial NCT07147192?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07147192 being conducted?

This trial has 5 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aphakia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aphakia

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.